Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ · Healthcare
Monte Rosa Therapeutics, Inc. Revenue 2023–2025
Monte Rosa Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Monte Rosa Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 4.2 M, a 95.04% decrease year-over-year.
- Monte Rosa Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 125.1 M, a 735.40% increase year-over-year.
- Monte Rosa Therapeutics, Inc. annual revenue for 2025 was 123.7 M, a 63.54% increase from 2024.
- Monte Rosa Therapeutics, Inc. annual revenue for 2024 was 75.6 M.
- Monte Rosa Therapeutics, Inc. annual revenue for 2023 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Monte Rosa Therapeutics, Inc. Earnings — FAQ
Monte Rosa Therapeutics, Inc. (GLUE) earnings over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GLUE's earnings history?
The chart and table above show Monte Rosa Therapeutics, Inc.'s earnings by year and by quarter, including the growth rate.